サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1463090

ウイルスクリアランス市場、シェア、規模、動向、産業分析レポート：方法別、用途別、エンドユーザー別、地域別、セグメント別予測、2024年～2032年

Viral Clearance Market Share, Size, Trends, Industry Analysis Report, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method); By Application; By End User; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ウイルスクリアランス市場、シェア、規模、動向、産業分析レポート：方法別、用途別、エンドユーザー別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年03月24日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のウイルスクリアランス市場規模は2032年までに14億6,476万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

バイオシミラーとジェネリック医薬品に対する世界の需要の高まりと、慢性疾患に対する高度で安価な治療に対するニーズの高まりが、市場成長を促進する顕著な要因となっています。さらに、開発の初期段階におけるウイルスクリアランスや不活性化の検出の普及が急速に進んでいることや、大手製薬企業やバイオテクノロジー企業の間でウイルスクリアランスのアウトソーシングに対する嗜好が高まっていることも、世界市場の成長をさらに押し上げると予想されます。

例えば、2023年6月、Texcell社は、北米に最新の試験施設を開設すると発表しました。これは、バイオ治療薬や医療機器のウイルス安全性向上に向けた同社の取り組みを示すものです。この新しい施設は、ウイルスクリアランスとバイオセーフティの同時試験をサポートするために特別に設計されています。

生物製剤中の有害ウイルスの検査には、いくつかの方法が用いられています。既知および未知の汚染ウイルスを正確かつ迅速に検出することが期待される次世代シーケンサーの登場により、その数はますます増えています。次世代シーケンサーは、広範囲のウイルス汚染物質の高感度かつ特異的な検査を可能にし、市場の成長ポテンシャルを生み出しています。例えば、2023年7月、Integrated DNA Technologies社は、「xGen Respiratory Virus Amplicon Panel」と呼ばれる新しい次世代シーケンスソリューションを発表しました。

さらに、ヒト免疫不全ウイルス、肝炎、ジカウイルスなど数種類のウイルス性疾患によって、ウイルスの安全性とヘルスケア産業におけるその重要性に対する認識が高まっています。また、遺伝子治療や個別化医療の必要性により、標的を絞った抗ウイルス治療や免疫反応の強化が可能になり、ひいては市場に大きな成長の可能性を生み出しています。

ウイルスクリアランス市場レポートハイライト

ウイルスクリアランス法分野は、その有益な特性と世界の新型ウイルスの脅威の台頭により、注目すべきシェアを占めました。

ワクチン部門が最大シェアを占めたが、これは患者の予防接種を促進するためのさまざまな種類のワクチンに対する需要とニーズの増加が背景にあります。

CRO分野は、初期段階の開発および試験サービスのアウトソーシングの普及により、大幅な成長率を示すと思われます。

巨大な未開拓市場の存在と可処分所得の増加により、アジア太平洋地域が最も急速に成長します。

北米は、ウイルスクリアランスの重要性に対する認識が高いことから、世界市場を席巻しています。

主な市場企業は、Charles River Laboratories、Merck KgaA、Syngene International Limited、WuXi Biologics、Clean Cells、Allure Medical Groupなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のウイルスクリアランス市場の洞察

  • ウイルスクリアランス市場- エンドユーザースナップショット
  • ウイルスクリアランス市場力学
    • 促進要因と機会
      • 生物製剤とワクチンの需要増加と研究開発費の増加が市場成長を推進する主な要因です。
      • ウイルス感染の増加
    • 抑制要因と課題
      • ウイルスクリアランス技術の複雑さ
  • PESTEL分析
  • ウイルスクリアランス市場のエンドユーザー動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のウイルスクリアランス市場、方法別

  • 主な調査結果
  • イントロダクション
  • ウイルスクリアランス方法
  • ウイルス不活化法
  • ウイルス検出方法

第6章 世界のウイルスクリアランス市場、用途別

  • 主な調査結果
  • イントロダクション
  • 血液および血液製剤
  • 組み換えタンパク質
  • 細胞・遺伝子治療製品
  • ワクチン
  • その他

第7章 世界のウイルスクリアランス市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 製薬・バイオテクノロジー業界
  • 学術研究機関
  • CRO
  • その他

第8章 世界のウイルスクリアランス市場、地域別

  • 主な調査結果
  • イントロダクション
    • ウイルスクリアランス市場の評価、地域別、2019年～2032年
  • ウイルスクリアランス市場-北米
    • 北米：ウイルスクリアランス市場、方法別、2019年～2032年
    • 北米：ウイルスクリアランス市場、エンドユーザー別、2019年～2032年
    • 北米：ウイルスクリアランス市場、用途別、2019年～2032年
    • ウイルスクリアランス市場-米国
    • ウイルスクリアランス市場- カナダ
  • ウイルスクリアランス市場- 欧州
    • 欧州：ウイルスクリアランス市場、方法別、2019年～2032年
    • 欧州：ウイルスクリアランス市場、エンドユーザー別、2019年～2032年
    • 欧州：ウイルスクリアランス市場、用途別、2019年～2032年
    • ウイルスクリアランス市場- 英国
    • ウイルスクリアランス市場- フランス
    • ウイルスクリアランス市場- ドイツ
    • ウイルスクリアランス市場- イタリア
    • ウイルスクリアランス市場- スペイン
    • ウイルスクリアランス市場- オランダ
    • ウイルスクリアランス市場- ロシア
  • ウイルスクリアランス市場- アジア太平洋
    • アジア太平洋：ウイルスクリアランス市場、方法別、2019年～2032年
    • アジア太平洋：ウイルスクリアランス市場、エンドユーザー別、2019年～2032年
    • アジア太平洋：ウイルスクリアランス市場、用途別、2019年～2032年
    • ウイルスクリアランス市場- 中国
    • ウイルスクリアランス市場- インド
    • ウイルスクリアランス市場- マレーシア
    • ウイルスクリアランス市場- 日本
    • ウイルスクリアランス市場- インドネシア
    • ウイルスクリアランス市場- 韓国
  • ウイルスクリアランス市場-中東・アフリカ
    • 中東・アフリカ：ウイルスクリアランス市場、方法別、2019年～2032年
    • 中東・アフリカ：ウイルスクリアランス市場、エンドユーザー別、2019年～2032年
    • 中東・アフリカ：ウイルスクリアランス市場、用途別、2019年～2032年
    • ウイルスクリアランス市場- サウジアラビア
    • ウイルスクリアランス市場-UAE
    • ウイルスクリアランス市場- イスラエル
    • ウイルスクリアランス市場- 南アフリカ
  • ウイルスクリアランス市場-ラテンアメリカ
    • ラテンアメリカ：ウイルスクリアランス市場、方法別、2019年～2032年
    • ラテンアメリカ：ウイルスクリアランス市場、エンドユーザー別、2019年～2032年
    • ラテンアメリカ：ウイルスクリアランス市場、用途別、2019年～2032年
    • ウイルスクリアランス市場- メキシコ
    • ウイルスクリアランス市場- ブラジル
    • ウイルスクリアランス市場- アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/展示会

第10章 企業プロファイル

  • Allure Medical Group
  • Charles River Laboratories
  • Clean Cells
  • Creative Biogene
  • Eurofins Scientific SE
  • Kedrion
  • Labor Dr. Merk & Kollegen GmbH
  • Merck KGaA
  • Microbiologics
  • Sartorius AG
  • Syngene International Limited
  • Texcell
  • ViruSure GmbH
  • Wuxi Biologics
図表

List of Tables

  • Table 1 Global Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 2 Global Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 4 Viral Clearance Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 6 North America: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 9 U.S.: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 12 Canada: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 15 Europe: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 18 UK: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 21 France: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 24 Germany: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 27 Italy: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 30 Spain: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 33 Netherlands: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 36 Russia: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 42 China: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 45 India: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 48 Malaysia: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 51 Japan: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 54 Indonesia: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 57 South Korea: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 66 UAE: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 69 Israel: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 72 South Africa: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 75 Latin America: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 78 Mexico: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 81 Brazil: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • Table 84 Argentina: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Viral Clearance Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Viral Clearance Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Viral Clearance Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Method
  • Figure 9. Global Viral Clearance Market, by Method, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Viral Clearance Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Viral Clearance Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Viral Clearance Market
目次
Product Code: PM4445

The global viral clearance market size is expected to reach USD 1464.76 million by 2032, according to a new study by Polaris Market Research. The report "Viral Clearance Market Share, Size, Trends, Industry Analysis Report, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method); By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing demand for biosimilars and generics worldwide and greater need for sophisticated and cheap therapies for chronic diseases, are prominent factors driving the market's growth. Additionally, the surging penetration for the detection of virus removal or inactivation during the early stages of development and rising preference for outsourcing of viral clearances among leading pharma and biotechnology companies, are further anticipated to boost global market growth.

For instance, in June 2023, Texcell, announced about the opening of its newest testing facility in North America that shows company's commitment towards advancing the viral safety of biotherapeutics and medical devices. The new facility is specially designed to support simultaneous viral clearance and biosafety studies.

There are several methods being used for testing of harmful viruses in biologics. There is an increasing proliferation for the advent of next-generation sequencing which holds great promise in accurate and fast detection of known and unknown contaminating viruses. It allows sensitive and specific testing of wide range of viral contaminants, creating a growth potential for the market. For instance, in July 2023, Integrated DNA Technologies, unveiled its new next-generation sequencing solution called "xGen Respiratory Virus Amplicon Panel".

Furthermore, there has been an increase in the awareness about viral safety and its significance in the healthcare industry, which has been underlined by several types of viral illnesses like Human Immunodeficiency Virus, hepatitis, and Zika virus. Also, the need for gene treatments and personalized medicine that allows for the development of targeted antiviral treatments and enhanced immune response, which in turn, generating huge growth potential for the market.

Viral Clearance Market Report Highlights

Viral removal method segment accounted for the noteworthy share, due to its beneficial properties and rising emergence of new virus threats globally

Vaccines segment held the largest share, that is driven by increasing demand and need for various types of vaccines to boost immunization of patient

CROs segment will grow at substantial growth rate, on account of growing prevalence for outsourcing of early-phase development and testing services

Asia Pacific will grow fastest, due to presence of huge untapped market and rising disposable income

North America dominated the global market, on account of region's greater awareness about the importance of viral clearance

The key market players include Charles River Laboratories, Merck KgaA, Syngene International Limited, WuXi Biologics, Clean Cells, and Allure Medical Group

Polaris Market Research has segmented the viral clearance market report based on method, application, end user, and region:

Viral Clearance, Method Outlook (Revenue - USD Million, 2019 - 2032)

  • Viral Removal Method
  • Viral Inactivation Method
  • Viral Detection Method

Viral Clearance, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Blood and Blood Products
  • Recombinant Proteins
  • Cellular & Gene
  • Therapy Products
  • Vaccines
  • Others

Viral Clearance, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical and Biotech Industry
  • Academic Research Institutes
  • CROs
  • Others

Viral Clearance, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Viral Clearance Market Insights

  • 4.1. Viral Clearance Market - End User Snapshot
  • 4.2. Viral Clearance Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing demand for biologics and vaccines and rise in R&D expenditure are major factors propelling market growth
      • 4.2.1.2. Rising Incidence of Viral Infections
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complexity of Viral Clearance Techniques
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Viral Clearance Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Viral Clearance Market, by Method

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Viral Clearance Market, by Method, 2019-2032 (USD Million)
  • 5.3. Viral Removal Method
    • 5.3.1. Global Viral Clearance Market, by Viral Removal Method, by Region, 2019-2032 (USD Million)
  • 5.4. Viral Inactivation Method
    • 5.4.1. Global Viral Clearance Market, by Viral Inactivation Method, by Region, 2019-2032 (USD Million)
  • 5.5. Viral Detection Method
    • 5.5.1. Global Viral Clearance Market, by Viral Detection Method, by Region, 2019-2032 (USD Million)

6. Global Viral Clearance Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • 6.3. Blood and Blood Products
    • 6.3.1. Global Viral Clearance Market, by Blood and Blood Products, by Region, 2019-2032 (USD Million)
  • 6.4. Recombinant Proteins
    • 6.4.1. Global Viral Clearance Market, by Recombinant Proteins, by Region, 2019-2032 (USD Million)
  • 6.5. Cellular & Gene Therapy Products
    • 6.5.1. Global Viral Clearance Market, by Cellular & Gene Therapy Products, by Region, 2019-2032 (USD Million)
  • 6.6. Vaccines
    • 6.6.1. Global Viral Clearance Market, by Vaccines, by Region, 2019-2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Viral Clearance Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Viral Clearance Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Viral Clearance Market, by End User, 2019-2032 (USD Million)
  • 7.3. Pharmaceutical and Biotech Industry
    • 7.3.1. Global Viral Clearance Market, by Pharmaceutical and Biotech Industry, By Region, 2019-2032 (USD Million)
  • 7.4. Academic Research Institutes
    • 7.4.1. Global Viral Clearance Market, by Academic Research Institutes, By Region, 2019-2032 (USD Million)
  • 7.5. CROs
    • 7.5.1. Global Viral Clearance Market, by CROs, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Viral Clearance Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Viral Clearance Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Viral Clearance Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Viral Clearance Market - North America
    • 8.3.1. North America: Viral Clearance Market, by Method, 2019-2032 (USD Million)
    • 8.3.2. North America: Viral Clearance Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Viral Clearance Market - U.S.
      • 8.3.4.1. U.S.: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Viral Clearance Market - Canada
      • 8.3.5.1. Canada: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • 8.4. Viral Clearance Market - Europe
    • 8.4.1. Europe: Viral Clearance Market, by Method, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Viral Clearance Market - UK
      • 8.4.4.1. UK: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Viral Clearance Market - France
      • 8.4.5.1. France: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Viral Clearance Market - Germany
      • 8.4.6.1. Germany: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Viral Clearance Market - Italy
      • 8.4.7.1. Italy: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Viral Clearance Market - Spain
      • 8.4.8.1. Spain: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Viral Clearance Market - Netherlands
      • 8.4.9.1. Netherlands: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Viral Clearance Market - Russia
      • 8.4.10.1. Russia: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • 8.5. Viral Clearance Market - Asia Pacific
    • 8.5.1. Asia Pacific: Viral Clearance Market, by Method, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Viral Clearance Market - China
      • 8.5.4.1. China: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Viral Clearance Market - India
      • 8.5.5.1. India: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Viral Clearance Market - Malaysia
      • 8.5.6.1. Malaysia: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Viral Clearance Market - Japan
      • 8.5.7.1. Japan: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Viral Clearance Market - Indonesia
      • 8.5.8.1. Indonesia: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Viral Clearance Market - South Korea
      • 8.5.9.1. South Korea: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • 8.6. Viral Clearance Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Viral Clearance Market, by Method, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Viral Clearance Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Viral Clearance Market - UAE
      • 8.6.5.1. UAE: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Viral Clearance Market - Israel
      • 8.6.6.1. Israel: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Viral Clearance Market - South Africa
      • 8.6.7.1. South Africa: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Viral Clearance Market, by Application, 2019-2032 (USD Million)
  • 8.7. Viral Clearance Market - Latin America
    • 8.7.1. Latin America: Viral Clearance Market, by Method, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Viral Clearance Market - Mexico
      • 8.7.4.1. Mexico: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Viral Clearance Market - Brazil
      • 8.7.5.1. Brazil: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Viral Clearance Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Viral Clearance Market - Argentina
      • 8.7.6.1. Argentina: Viral Clearance Market, by Method, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Viral Clearance Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Viral Clearance Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Allure Medical Group
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Charles River Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Clean Cells
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Creative Biogene
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eurofins Scientific SE
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Kedrion
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Labor Dr. Merk & Kollegen GmbH
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Merck KGaA
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Microbiologics
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sartorius AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Syngene International Limited
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Texcell
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. ViruSure GmbH
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Wuxi Biologics
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development